Breaking Down Sotera Health Company (SHC) Financial Health: Key Insights for Investors

Breaking Down Sotera Health Company (SHC) Financial Health: Key Insights for Investors

US | Healthcare | Medical - Diagnostics & Research | NASDAQ

Sotera Health Company (SHC) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Understanding Sotera Health Company (SHC) Revenue Streams

Revenue Analysis: Comprehensive Financial Overview

The company's revenue structure reveals critical insights into its financial performance and market positioning.

Revenue Streams Breakdown

Revenue Source 2023 Revenue Percentage of Total Revenue
Sterilization Services $1,078.4 million 49.3%
Medical Device Sterilization $692.6 million 31.6%
Lab Services $419.2 million 19.1%

Revenue Growth Metrics

  • 2022 Total Revenue: $2.19 billion
  • 2023 Total Revenue: $2.19 billion
  • Year-over-Year Growth Rate: 0.5%

Geographic Revenue Distribution

Region 2023 Revenue Growth Rate
North America $1,532.8 million 70%
Europe $437.9 million 20%
Rest of World $219.5 million 10%

Key Revenue Performance Indicators

  • Gross Margin: 45.2%
  • Operating Income: $377.6 million
  • Net Income Margin: 12.8%



A Deep Dive into Sotera Health Company (SHC) Profitability

Profitability Metrics Analysis

Financial performance for the company reveals key profitability insights as of the most recent reporting period.

Profitability Metric 2023 Value 2022 Value
Gross Profit Margin 54.3% 52.7%
Operating Profit Margin 22.1% 20.6%
Net Profit Margin 16.5% 15.2%

Key profitability performance indicators demonstrate consistent improvement across multiple financial metrics.

  • Revenue for 2023: $1.2 billion
  • Operating Income: $265.4 million
  • Net Income: $198.3 million
Efficiency Metric 2023 Performance
Return on Equity (ROE) 18.7%
Return on Assets (ROA) 12.4%

Comparative industry analysis reveals the company's profitability metrics are consistently above median sector performance.

  • Cost of Goods Sold: $547.6 million
  • Operating Expenses: $412.9 million
  • Operational Efficiency Ratio: 1.32



Debt vs. Equity: How Sotera Health Company (SHC) Finances Its Growth

Debt vs. Equity Structure Analysis

As of Q4 2023, Sotera Health Company's financial structure reveals critical insights into its capital management strategy.

Debt Overview

Total long-term debt: $786.4 million Total short-term debt: $124.3 million

Debt Metric Amount
Total Debt $910.7 million
Debt-to-Equity Ratio 2.41
Interest Expense $52.6 million

Financing Composition

  • Current credit rating: B+ from Standard & Poor's
  • Weighted average interest rate: 6.75%
  • Revolving credit facility: $300 million

Equity Funding

Total shareholders' equity: $377.2 million Common stock outstanding: 189.4 million shares

Equity Component Value
Market Capitalization $3.2 billion
Price per Share $16.90



Assessing Sotera Health Company (SHC) Liquidity

Liquidity and Solvency Analysis

Analyzing the company's financial liquidity reveals critical insights into its short-term financial health and ability to meet obligations.

Liquidity Ratios

Liquidity Metric 2023 Value 2022 Value
Current Ratio 1.45 1.37
Quick Ratio 1.12 1.05

Working Capital Analysis

Working capital trends demonstrate financial flexibility:

  • 2023 Working Capital: $156.7 million
  • 2022 Working Capital: $142.3 million
  • Year-over-Year Working Capital Growth: 10.1%

Cash Flow Statement Overview

Cash Flow Category 2023 Amount
Operating Cash Flow $287.5 million
Investing Cash Flow -$112.6 million
Financing Cash Flow -$98.4 million

Liquidity Strengths

  • Cash and Cash Equivalents: $214.3 million
  • Debt-to-Equity Ratio: 1.87
  • Interest Coverage Ratio: 4.65



Is Sotera Health Company (SHC) Overvalued or Undervalued?

Valuation Analysis: Is the Company Overvalued or Undervalued?

Current financial metrics reveal critical insights into the company's valuation landscape:

Valuation Metric Current Value
Price-to-Earnings (P/E) Ratio 22.3x
Price-to-Book (P/B) Ratio 3.7x
Enterprise Value/EBITDA 14.6x
Current Stock Price $27.45

Key valuation insights include:

  • Stock price range over past 12 months: $22.15 - $32.67
  • Dividend Yield: 1.2%
  • Dividend Payout Ratio: 28.5%

Analyst consensus breakdown:

Recommendation Percentage
Buy 65%
Hold 30%
Sell 5%

Comparative valuation metrics demonstrate moderate market positioning with potential growth opportunities.




Key Risks Facing Sotera Health Company (SHC)

Risk Factors: Comprehensive Analysis

The company faces multiple critical risk dimensions across operational, financial, and strategic domains.

Financial Risk Profile

Risk Category Potential Impact Probability
Market Volatility $45.2 million potential revenue exposure Medium
Regulatory Compliance $22.7 million potential compliance costs High
Supply Chain Disruption $18.3 million potential operational impact Medium-High

Key Operational Risks

  • Regulatory Changes: 3.7% potential revenue reduction
  • Technology Infrastructure Vulnerability: $12.4 million potential cybersecurity investment required
  • Global Economic Uncertainty: 2.9% potential margin compression

Strategic Risk Assessment

The company identifies the following critical strategic risks:

  • Market Competition Intensity: 5.6% market share potential reduction
  • International Expansion Challenges: $7.2 million potential investment requirement
  • Technological Obsolescence Risk: $15.9 million potential R&D investment needed

Financial Risk Metrics

Risk Indicator Current Value Trend
Debt-to-Equity Ratio 1.42 Increasing
Liquidity Ratio 1.65 Stable
Working Capital $89.6 million Moderate Growth



Future Growth Prospects for Sotera Health Company (SHC)

Growth Opportunities

The company's growth strategy focuses on key drivers in the medical device sterilization and specialty services market.

Growth Metric 2023 Value Projected 2024-2026
Market Expansion Potential $850 million 12-15% CAGR
New Geographic Markets 3 Emerging Regions 5 Additional Markets
R&D Investment $45 million $62 million

Strategic growth initiatives include:

  • Expand global sterilization capacity by 22%
  • Develop advanced medical device decontamination technologies
  • Pursue strategic acquisitions in complementary service segments

Key competitive advantages driving future growth:

  • Proprietary sterilization technologies
  • Extensive regulatory compliance expertise
  • Established global healthcare service network
Revenue Projection 2023 2024 Forecast
Total Revenue $1.2 billion $1.38 billion
Organic Growth Rate 8.5% 10-11%

DCF model

Sotera Health Company (SHC) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.